(1 - 5 von 15
)
BioCardia and Juventas to start phase II trial for heart failure treatmentcardiovascularnews.com › News
cardiovascularnews.com
· ... I clinical trial and is an attractive delivery system for our targeted patient population,” said Rahul Aras, president and CEO Juventas.
The Alliance for Regenerative Medicine Names 32 Member...
www.wallstreet-online.de
Rahul Aras, President and CEO, Juventas Usman Azam, Global Head Cell & Gene Therapies Unit, Novartis Doug Doerfler, President & CEO, MaxCyte
sironrx gets third frontier funding for clinical trials, staff growthwww.freshwatercleveland.com › sironrx
www.freshwatercleveland.com
· ... product,” explains Rahul Aras, SironRX president and CEO. “With SRX100, we accelerate treatment in dermal wounds and prevent scarring.
sortiert nach Relevanz / Datum